Analysis of information sources in references of the Wikipedia article "إطالة الحياة" in Arabic language version.
{{استشهاد بدورية محكمة}}: تحقق من التاريخ في: |تاريخ الوصول= (مساعدة)In animal models, alterations in GH/IGF-1 signaling with reductions in these somatotrophs appear to increase life span. ... Administration of IGF-1Eb (mechanogrowth factor) stimulates proliferation of myoblasts and induces muscle hypertrophy. Increases in GH and IGF-1 during adolescence are beneficial for brain and cardiovascular function during the aging process and GH administration during adolescence is vasoprotective and increases life-span.15 ... Studies relating GH and IGF-1 status to longevity provide inconsistent evidence as to whether decreased (somatopause) or high levels (e.g. acromegaly) of these hormones are beneficial or detrimental to longevity. ... It is difficult to reconcile the largely protective effects of GH/IGF-1 deficiency on longevity in animals with the inconsistent or deleterious effects of low levels or declining GH/IGF-1 during human aging.
{{استشهاد بدورية محكمة}}: تحقق من التاريخ في: |تاريخ الوصول= (مساعدة){{استشهاد بدورية محكمة}}: تحقق من التاريخ في: |تاريخ الوصول= (مساعدة)In animal models, alterations in GH/IGF-1 signaling with reductions in these somatotrophs appear to increase life span. ... Administration of IGF-1Eb (mechanogrowth factor) stimulates proliferation of myoblasts and induces muscle hypertrophy. Increases in GH and IGF-1 during adolescence are beneficial for brain and cardiovascular function during the aging process and GH administration during adolescence is vasoprotective and increases life-span.15 ... Studies relating GH and IGF-1 status to longevity provide inconsistent evidence as to whether decreased (somatopause) or high levels (e.g. acromegaly) of these hormones are beneficial or detrimental to longevity. ... It is difficult to reconcile the largely protective effects of GH/IGF-1 deficiency on longevity in animals with the inconsistent or deleterious effects of low levels or declining GH/IGF-1 during human aging.
In animal models, alterations in GH/IGF-1 signaling with reductions in these somatotrophs appear to increase life span. ... Administration of IGF-1Eb (mechanogrowth factor) stimulates proliferation of myoblasts and induces muscle hypertrophy. Increases in GH and IGF-1 during adolescence are beneficial for brain and cardiovascular function during the aging process and GH administration during adolescence is vasoprotective and increases life-span.15 ... Studies relating GH and IGF-1 status to longevity provide inconsistent evidence as to whether decreased (somatopause) or high levels (e.g. acromegaly) of these hormones are beneficial or detrimental to longevity. ... It is difficult to reconcile the largely protective effects of GH/IGF-1 deficiency on longevity in animals with the inconsistent or deleterious effects of low levels or declining GH/IGF-1 during human aging.
{{استشهاد بدورية محكمة}}: تحقق من التاريخ في: |تاريخ الوصول= (مساعدة){{استشهاد بدورية محكمة}}: تحقق من التاريخ في: |تاريخ الوصول= (مساعدة)